The inhibitory effects of 130 and tetrahydrocurcumin 131 on MAO-B were evaluated in a Parkinson’s disease rodent model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. The gene discussed is MAOB; the disease is Parkinson disease.